Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_assertion type Assertion NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_head.
- NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_assertion description "[We examined the association between 36 genotyped and 193 imputed SNPs within four lipid-lowering drug target genes (HMGCR, PPARA, HM74A/GPR109A and CETP) and four non-lipid drug target genes (ACE, AGTR1, P2RY12, and ATP4B) and lipid phenotypes, blood pressure, and coronary artery disease in 5635 adult participants of the Lausanne, Switzerland, CoLaus study, genotyped using the Affymetrix 500K SNP chip technology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_provenance.
- NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_assertion evidence source_evidence_literature NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_provenance.
- NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_assertion SIO_000772 18787507 NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_provenance.
- NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_assertion wasDerivedFrom befree-20150227 NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_provenance.
- NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_assertion wasGeneratedBy ECO_0000203 NP985318.RA3IOF6858utQ4Z7LQ0LyZwRrJWy9mFNtf945_mwXaRDc130_provenance.